CN110859775A - Application of glycerol glucoside in transdermal absorption composition - Google Patents
Application of glycerol glucoside in transdermal absorption composition Download PDFInfo
- Publication number
- CN110859775A CN110859775A CN201911221561.3A CN201911221561A CN110859775A CN 110859775 A CN110859775 A CN 110859775A CN 201911221561 A CN201911221561 A CN 201911221561A CN 110859775 A CN110859775 A CN 110859775A
- Authority
- CN
- China
- Prior art keywords
- glycerol glucoside
- composition
- glucoside
- glycerol
- transdermal absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title claims abstract description 129
- -1 glycerol glucoside Chemical class 0.000 title claims abstract description 64
- 229930182478 glucoside Natural products 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 37
- 230000000694 effects Effects 0.000 claims abstract description 13
- 230000002087 whitening effect Effects 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims description 21
- 239000002537 cosmetic Substances 0.000 claims description 16
- 239000003623 enhancer Substances 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 6
- 239000000017 hydrogel Substances 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000005414 inactive ingredient Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000003961 penetration enhancing agent Substances 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 238000009825 accumulation Methods 0.000 claims description 2
- 210000001789 adipocyte Anatomy 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 230000037384 skin absorption Effects 0.000 claims description 2
- 231100000274 skin absorption Toxicity 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 230000003833 cell viability Effects 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 23
- 230000035515 penetration Effects 0.000 abstract description 14
- 238000011160 research Methods 0.000 abstract description 9
- 230000003020 moisturizing effect Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000013543 active substance Substances 0.000 abstract description 2
- 210000004207 dermis Anatomy 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 210000000434 stratum corneum Anatomy 0.000 description 7
- 239000010410 layer Substances 0.000 description 5
- 230000035790 physiological processes and functions Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses application of glycerol glucoside in a transdermal absorption composition. The invention researches and proves for the first time that the application of the glycerol glucoside with higher concentration can obviously improve the transdermal absorption capacity and the penetration rate of the glycerol glucoside, thereby enhancing the absorption effect of the composition, being beneficial to the active substances of the prepared composition to penetrate through the horny layer to reach the corresponding dermis layer or other skin layers, leading the composition to have better effects of moisturizing, skin care, whitening and the like, expanding the application of the glycerol glucoside and having good value of practical application.
Description
Technical Field
The invention belongs to the technical field of medicines/cosmetics, and particularly relates to application of glycerol glucoside in a transdermal absorption composition.
Background
The information in this background section is only for enhancement of understanding of the general background of the invention and is not necessarily to be construed as an admission or any form of suggestion that this information forms the prior art that is already known to a person of ordinary skill in the art.
Glycerol Glucosides (GG) are glycoside compounds formed by connecting glycerol molecules and glucose molecules through glycosidic bonds, and 6 different steric structures exist in nature according to the difference between the steric configurations (α and β) and the glycosidic bond connection positions, wherein the structure with important physiological functions is 2- α configuration (GG represents 2- α GG when not particularly explained below), and researches prove that the GG has the main extremely strong skin moisturizing function and is initially applied to cosmetics.
The primary barrier function of the skin to restrict the communication of substances in and out of the body comes from the compact structure of the stratum corneum. The rate of penetration of the stratum corneum by the substance in vitro is also the major rate-limiting step in transdermal absorption. Taking a human body as an example, the stratum corneum of human skin is the outermost layer of epidermis and consists of 4-8 dead flat lamellar anucleated cells. Among them, keratinocytes together with intercellular lipids constitute the most basic protective layer of the outermost layer of the skin, called the "skin barrier".
The stratum corneum can protect the skin, prevent in vivo interstitial fluid from exosmosis, limit the barrier function of water, lipid or cosmetic ingredient skin stratum corneum, the stratum corneum has hindered the percutaneous permeation of most foreign substances, there is research that, in the transdermal experiment of the separation, after stripping the stratum corneum of skin, the permeability of the substance can be increased by tens of times or even hundreds of times. However, regarding the research on transdermal absorption, at present, many studies on transdermal absorption of drugs are conducted at home and abroad, and the research mainly focuses on several aspects such as drug penetration characteristics, pharmacokinetic analysis, selection of penetration enhancer and the like, while the research on cosmetic transdermal absorbents and action mechanisms is very limited.
Meanwhile, at present, the cell physiological function of GG is only limited to cell culture tests, and the skin transdermal property and the skin penetration rate of GG determine the practical application of the cell physiological function of GG to a certain extent, however, no report about whether GG can be absorbed transdermally is available at present.
Disclosure of Invention
In view of the above-mentioned deficiencies of the prior art, the present invention provides a use of glycerol glucoside in a transdermal absorption composition. Researches prove that the transdermal absorption capacity and the permeability of the GG can be remarkably improved by improving the concentration of the glycerol glucoside in a proper concentration range, so that a feasible theoretical basis is provided for expanding the application of other compositions except for a moisturizing product.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect of the invention, there is provided the use of a glycerol glucoside in the preparation of a penetration enhancer for transdermal absorption.
In a second aspect of the present invention, there is provided a transdermal absorption enhancer, wherein the active ingredient of the transdermal absorption enhancer contains at least glycerol glucoside.
In a third aspect of the present invention, there is provided the use of the above-mentioned glycerol glucoside and/or transdermal absorption enhancer for the preparation of a transdermal absorption composition.
The composition includes, but is not limited to, cosmetics and pharmaceuticals, and further preferably cosmetics.
The composition has any one or more of the following uses:
1) moisture preservation;
2) whitening;
3) anti-aging;
4) the elasticity of the skin is increased;
5) repairing the cells.
According to the present invention, not only the effect of glycerol glucoside as a means for preparing a transdermal absorption composition is disclosed, but also it is disclosed that such effect can be enhanced when glycerol glucoside is administered in combination with at least one other active ingredient, such as a cosmetic active ingredient or a pharmaceutical active ingredient. As an alternative or in addition to the other active ingredients, it is also possible to use them in combination with other inactive ingredients.
In view of the above, the fourth aspect of the present invention discloses a cosmetic or pharmaceutical composition with transdermal absorption, which is composed of glycerol glucoside and at least one other active ingredient and/or at least one other active ingredient.
According to the use of the invention, the administration of the composition can be carried out topically, transdermally, as an aerosol or dry powder formulation. Specific dosage forms of the composition include, but are not limited to, sprays, creams, ointments, lotions, emulsions, gels or hydrogels.
The invention has the beneficial effects that:
the invention researches and proves for the first time that the application of the glycerol glucoside with higher concentration can obviously improve the transdermal absorption capacity and the penetration rate of the glycerol glucoside, thereby enhancing the absorption effect of the composition, being beneficial to the active substances of the prepared composition to penetrate through the horny layer to reach the corresponding dermis layer or other skin layers, leading the composition to have better effects of moisturizing, skin care, whitening and the like, expanding the application of the glycerol glucoside and having good value of practical application.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings needed to be used in the description of the embodiments are briefly introduced below, and it is obvious that the drawings in the following description are only embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings according to the provided drawings without creative efforts.
FIG. 1 is a graph of the cumulative mean osmolarity of glycerol glucoside at various concentrations in accordance with the present invention.
FIG. 2 is a graph of mean permeability of glycerol glucoside at different concentrations according to the present invention.
Detailed Description
It is to be understood that the following detailed description is exemplary and is intended to provide further explanation of the invention as claimed. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments in accordance with the present application. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, and it should be understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of stated features, steps, operations, devices, components, and/or combinations thereof, unless the context clearly indicates otherwise.
As mentioned above, at present, the cell physiological function of the glycerol glucoside is only limited to cell culture tests, and the skin transdermal property and the skin penetration rate of the glycerol glucoside determine the practical application of the cell physiological function of the glycerol glucoside to a certain extent, however, at present, no report on whether the glycerol glucoside can be transdermally absorbed through skin exists.
In view of the above, one embodiment of the present invention discloses the use of glycerol glucoside in the preparation of transdermal penetration enhancers.
In another embodiment of the present invention, the effective concentration of the glycerol glucoside is not less than 10mg/mL, more preferably 10 to 20mg/mL, and still more preferably 20 mg/mL.
In another embodiment of the present invention, there is provided a transdermal absorption enhancer, wherein the active ingredient of the transdermal absorption enhancer contains at least glycerol glucoside.
The effective concentration of the glycerol glucoside is not less than 10mg/mL, further 10-20 mg/mL, and further 20 mg/mL.
In another embodiment of the present invention, there is provided a use of the above-mentioned glycerol glucoside and/or transdermal absorption enhancer for the preparation of a transdermal absorption composition.
In yet another embodiment of the present invention, the composition includes, but is not limited to, cosmetics and pharmaceuticals, and further preferably cosmetics.
In another embodiment of the present invention, the effective concentration of the glycerol glucoside is not less than 10mg/mL, more preferably 10 to 20mg/mL, and still more preferably 20 mg/mL.
In yet another embodiment of the invention, the composition has any one or more of the following uses:
1) moisture preservation;
2) whitening;
3) anti-aging;
4) the elasticity of the skin is increased;
5) repairing the cells.
The experimental research proves that the transdermal absorption capacity and the permeability of the glycerol glucoside can be effectively improved by improving the concentration of the glycerol glucoside in a proper range, so that the application of the glycerol glucoside in the fields of cosmetics and the like is effectively expanded. Therefore, the composition containing the glycerol glucoside with higher effective concentration is not only suitable for nursing daily skin, but also suitable for the problem skin with fatigue, stress (such as UV radiation and PM2.5 pollution relief), aging, sensitivity, eczema and the like.
According to the present invention, not only the effect of glycerol glucoside as a means for preparing a transdermal absorption composition is disclosed, but also it is disclosed that such effect can be enhanced when glycerol glucoside is administered in combination with at least one other active ingredient, such as a cosmetic active ingredient or a pharmaceutical active ingredient. As an alternative or in addition to the other active ingredients, it is also possible to use them in combination with other inactive ingredients.
In view of the above, in yet another embodiment of the present invention, a transdermally absorbable cosmetic or pharmaceutical composition comprising glycerol glucoside and at least one other active ingredient and/or at least one other active ingredient is disclosed.
Wherein other active ingredients have the effects of promoting skin absorption or inhibiting accumulation of neutral lipid in fat cells, improving cell activity, and improving cell hyaluronic acid and collagen synthesis.
Other inactive ingredients include pharmaceutically/cosmetically acceptable carriers, excipients and/or diluents. Such as pharmaceutically compatible inorganic or organic acids or bases, polymers, copolymers, block copolymers, monosaccharides, polysaccharides, ionic and non-ionic surfactants or lipids, pharmacologically harmless salts such as sodium chloride, flavoring agents, vitamins such as vitamin a or vitamin E, tocopherols or similar vitamins or provitamins present in the human organism, antioxidants such as ascorbic acid, and stabilizers and/or preservatives for prolonging the use and shelf life of the pharmaceutically active ingredient or formulation, and other common non-pharmaceutically active ingredients or adjuvants and additives known in the art, and mixtures thereof. Other non-pharmaceutically active ingredients preferred according to the invention are in particular all substances which can form hydrogels, for example natural or synthetic water-soluble polymers which can form networks.
According to the use of the invention, the administration of the composition can be carried out topically, transdermally, as an aerosol or dry powder formulation. Specific dosage forms of the composition include, but are not limited to, sprays, creams, ointments, lotions, emulsions, gels or hydrogels.
The mode of application is preferably topical and transdermal, by applying the composition on the skin, preferably a liquid, gas (aerosol or vapor), formulation containing the glycerol glucoside, preferably as a cream, ointment, lotion, emulsion, or gel or hydrogel.
Wherein the effective concentration of the glycerol glucoside is not less than 10mg/mL, further 10-20 mg/mL, and further 20 mg/mL.
The preferred topical or transdermal application according to the invention allows to apply a high effective glycerol glucoside concentration locally on the skin, to promote the penetration of the active principle (including glycerol glucoside) into the epidermal cells for repair, hydration, etc., while reducing or completely avoiding the load of the system (blood circulation) and possible side effects on healthy skin tissues and tissues of other organs which do not require application.
In still another embodiment of the present invention, the glycerol glucoside has a 2- α configuration.
The present invention is further illustrated, but is not intended to be limited, by the following examples, which are set forth in the accompanying drawings, it being understood that these examples are included merely for purposes of illustration and are not intended to limit the scope of the invention, the glycerol glucosides in the examples being in the 2- α configuration.
Example 1
A transdermal absorption enhancer, which contains an aqueous solution of glycerol glucoside, wherein the concentration of the glycerol glucoside is 10 mg/mL.
Example 2
A transdermal absorption enhancer, which contains an aqueous solution of glycerol glucoside, wherein the concentration of the glycerol glucoside is 20 mg/mL.
Example 3
A transdermal absorption moisturizing cosmetic is composed of the following components in percentage by mass: cetyl alcohol 4%, horse oil 10%, jojoba oil 10%, methyl glucoside sesquistearate 4%, glycerol glucoside 10%, Brobopol 0.1%, and water in balance, wherein the concentration of glycerol glucoside is 10 mg/mL.
Example 4
A transdermal absorption moisturizing cosmetic is composed of the following components in percentage by mass: octadecanol 4%, horse oil 10%, jojoba oil 10%, methyl glucoside sesquistearate 4%, glycerol glucoside 20%, Broboer 0.1%, and water in balance, wherein the concentration of glycerol glucoside is 20 mg/mL.
Effect verification
1. Materials and methods
1.1 test materials
Test compositions: 10mg/mL Glycerol glucoside (aqueous solution), 20mg/mL Glycerol glucoside (aqueous solution)
1.2 instrumentation
TT-8 percutaneous absorption instrument, ion chromatograph and high performance liquid chromatograph
1.3 test methods
Stripping the abdominal skin of the mouse, preparing glycerol glucoside (10mg/mL and 20mg/mL) with different concentration gradients by using the mouse skin and a transdermal absorption instrument, repeating the steps for three times at each concentration, sampling and determining the content of the glycerol glucoside after 1h, 2h, 4h, 6h, 8h and 12h respectively, and calculating the accumulated penetration amount.
2. Results and analysis
And calculating the unit area penetration amount and the accumulated penetration amount according to the GG content results at different time points, repeatedly averaging for three times, and obtaining the accumulated average penetration amount and average penetration rate results of GG with different concentrations as shown in figures 1 and 2. When the concentration of GG is increased, the transdermal absorption amount shows a great increase trend, and the average penetration rate is increased from 3.1% to 15.12%.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (10)
1. Application of glycerol glucoside in preparing transdermal absorption penetration enhancer is provided.
2. The use according to claim 1, wherein the effective concentration of the glycerol glucoside is not less than 10mg/mL, further 10 to 20mg/mL, and further 20 mg/mL.
3. A percutaneous absorption enhancer, wherein the active component of the percutaneous absorption enhancer at least contains glycerol glucoside;
preferably, the effective concentration of the glycerol glucoside is not less than 10mg/mL, further 10-20 mg/mL, and further 20 mg/mL.
4. Use of a glycerol glucoside and/or a transdermal penetration enhancer of claim 3 in the preparation of a transdermal composition.
5. Use according to claim 4, wherein the composition comprises cosmetics and pharmaceuticals, preferably cosmetics.
6. The use according to claim 5, wherein the effective concentration of the glycerol glucoside is not less than 10mg/mL, further 10-20 mg/mL, and further 20 mg/mL.
7. The use according to any one of claims 4 to 6, wherein the composition has any one or more of the following uses:
1) moisture preservation;
2) whitening;
3) anti-aging;
4) the elasticity of the skin is increased;
5) repairing the cells.
8. A transdermal absorption composition comprising glycerol glucoside and at least one other active ingredient and/or at least one other active ingredient.
9. The composition of claim 8, wherein the other active ingredients have at least one of effects of promoting skin absorption or inhibiting accumulation of neutral lipids in adipocytes, improving cell viability, and increasing cellular hyaluronic acid and collagen synthesis;
other inactive ingredients include pharmaceutically/cosmetically acceptable carriers, excipients and/or diluents.
10. The composition of claim 8, wherein the composition is in a dosage form comprising a spray, cream, ointment, lotion, emulsion, gel, or hydrogel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911221561.3A CN110859775A (en) | 2019-12-03 | 2019-12-03 | Application of glycerol glucoside in transdermal absorption composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911221561.3A CN110859775A (en) | 2019-12-03 | 2019-12-03 | Application of glycerol glucoside in transdermal absorption composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110859775A true CN110859775A (en) | 2020-03-06 |
Family
ID=69658180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911221561.3A Pending CN110859775A (en) | 2019-12-03 | 2019-12-03 | Application of glycerol glucoside in transdermal absorption composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110859775A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712841A (en) * | 2021-11-01 | 2021-11-30 | 深圳市萱嘉生物科技有限公司 | Application of glycerol glucoside in preparation of oral care product |
| CN115252466A (en) * | 2022-08-22 | 2022-11-01 | 青岛中科蓝智生物科技发展有限公司 | Application of polysaccharides and derivatives thereof in freckle removing and whitening products |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090130223A1 (en) * | 2006-04-27 | 2009-05-21 | Ute Breitenbach | Cosmetic preparation with aquaporin stimulators and the use thereof |
| CN105687061A (en) * | 2016-04-15 | 2016-06-22 | 广州宝生堂化妆品有限公司 | Composition with skin repairing function |
| CN107252427A (en) * | 2012-07-09 | 2017-10-17 | 比托普股份公司 | For the composition for including active material for the bodily tissue regeneration for promoting damage |
| CN109998937A (en) * | 2019-03-22 | 2019-07-12 | 南京工业大学 | Serial cosmetics and preparation method thereof containing glycosylglycerol (α GG) |
-
2019
- 2019-12-03 CN CN201911221561.3A patent/CN110859775A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090130223A1 (en) * | 2006-04-27 | 2009-05-21 | Ute Breitenbach | Cosmetic preparation with aquaporin stimulators and the use thereof |
| CN107252427A (en) * | 2012-07-09 | 2017-10-17 | 比托普股份公司 | For the composition for including active material for the bodily tissue regeneration for promoting damage |
| CN105687061A (en) * | 2016-04-15 | 2016-06-22 | 广州宝生堂化妆品有限公司 | Composition with skin repairing function |
| CN109998937A (en) * | 2019-03-22 | 2019-07-12 | 南京工业大学 | Serial cosmetics and preparation method thereof containing glycosylglycerol (α GG) |
Non-Patent Citations (1)
| Title |
|---|
| A. SCHRADER等: "《Effects of Glyceryl Glucoside on AQP3 Expression, Barrier Function and Hydration of Human Skin》", 《SKIN PHARMACOL PHYSIOL》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712841A (en) * | 2021-11-01 | 2021-11-30 | 深圳市萱嘉生物科技有限公司 | Application of glycerol glucoside in preparation of oral care product |
| CN115252466A (en) * | 2022-08-22 | 2022-11-01 | 青岛中科蓝智生物科技发展有限公司 | Application of polysaccharides and derivatives thereof in freckle removing and whitening products |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6227856B2 (en) | Composition and method for skin care | |
| AU2012254214B2 (en) | A topical formulation for treatment of hyperkeratotic skin | |
| AU2012254214A1 (en) | A topical formulation for treatment of hyperkeratotic skin | |
| CN110859775A (en) | Application of glycerol glucoside in transdermal absorption composition | |
| EP2763686A1 (en) | Composition for the treatment of skin lesions | |
| KR101502475B1 (en) | Use of a lipophilic extract of odontella aurita to restructure the skin, compositions used and cosmetic method employing said extract | |
| US20150119427A1 (en) | Waterborne topical compositions for the delivery of azelaic acid for treatment of skin conditions such as acne vulgaris, rosacea, seborrheic dermatitis | |
| CN110859756A (en) | Liquid crystal sustained-release system for promoting transdermal absorption of cordyceps sinensis and preparation method and application thereof | |
| KR100534185B1 (en) | Moisturizing cosmetic compositions containing a beta-1,6-branched-beta-1,3-glucan | |
| TWI801711B (en) | Composition for restoring the skin barrier and use thereof | |
| EP3485872A1 (en) | Compositions comprising hyaluronic acid and h2 | |
| JP6656890B2 (en) | Filaggrin production promoter | |
| Marini et al. | Urea and skin: A well-known molecule revisited | |
| Davel | Topical delivery of niacinamide, encapsulated in niosome and proniosome carriers | |
| JP2023083229A (en) | Non-woven fabric impregnated topical composition | |
| TW202009002A (en) | Use of extract of Sphagneticola trilobata for anti-inflammation of skin and promoting keratinocyte proliferation | |
| KR20060071661A (en) | Skin care cosmetic compositions containing extracts of lycopus lucidus turcz | |
| KR20000044978A (en) | Enhancer composition for stratum cornea exfoliation | |
| JPH11209285A (en) | Ceramide synthesis promoter | |
| US20090105191A1 (en) | Pharmaceutical and Dermatocosmetic Compositions Comprising Extract of Durio Zibenthinus | |
| WO2015179570A1 (en) | Waterborne topical compositions for the delivery of azelaic acid for treatment of skin conditions such as acne vulgaris, rosacea seborrheic dermatitis | |
| JPH0246003B2 (en) | ||
| KR20100067717A (en) | Skin care cosmetic compositions containing extracts of punica granatum linne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210907 Address after: 266101 Shandong Province, Qingdao city Laoshan District Songling Road No. 189 Applicant after: Qingdao Zhongke Lanzhi Biotechnology Development Co.,Ltd. Address before: 266101 Shandong Province, Qingdao city Laoshan District Songling Road No. 189 Applicant before: QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200306 |
|
| RJ01 | Rejection of invention patent application after publication |